Ann Intern Med

1. RADCLIFFE C, Kotton CN
   En Garde or On Board? Travel Medicine for Immunocompromised Patients in the COVID-19 Era.
   Ann Intern Med. 2024 Apr 9. doi: 10.7326/M24-0256.
   

   >> Share

   
   

   
   Antiviral Res

2. TOLKSDORF B, Heinze J, Niemeyer D, Rohrs V, et al
   Development of a highly stable, active small interfering RNA with broad activity against SARS-CoV viruses.
   Antiviral Res. 2024 Apr 8:105879. doi: 10.1016/j.antiviral.2024.105879.
   

   >> Share

   
   

   
   Clin Infect Dis

3. MCAULEY JB
   COVID at the Whiteriver Indian Hospital.
   Clin Infect Dis. 2024;78:815-817.
   

   >> Share

   
   
4. ZAWADZKA S
   Family Ties and COVID Lies.
   Clin Infect Dis. 2024;78:813-814.
   

   >> Share

   
   
5. TIPPETT A, Ess G, Hussaini L, Reese O, et al
   Influenza Vaccine Effectiveness Pre-pandemic among Adults Hospitalized with Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and Older Adults.
   Clin Infect Dis. 2023 Nov 8:ciad679. doi: 10.1093.
   

   >> Share

   
   
6. VAN DER VAART TW, Prins JM, Goorhuis A, Lemkes BA, et al
   The utility of risk factors to define complicated Staphylococcus aureus bacteremia in a setting with low MRSA prevalence.
   Clin Infect Dis. 2023 Dec 29:ciad784. doi: 10.1093.
   

   >> Share

   
   
7. SHERMAN A, Tuan J, Cantos VD, Adeyiga O, et al
   COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
   Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093.
   

   >> Share

   
   
8. PETROS BA, Milliren CE, Sabeti PC, Ozonoff A, et al
   Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of Severe Acute Respiratory Syndrome Coronavirus 2 Can Be Attributed to Changes in Testing.
   Clin Infect Dis. 2024 Apr 11:ciae140. doi: 10.1093.
   

   >> Share

   
   
9. RUBIS AB, Cole M, Tondella ML, Pawloski LC, et al
   Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases.
   Clin Infect Dis. 2024 Apr 12:ciae207. doi: 10.1093.
   

   >> Share

   
   

   
   Int J Infect Dis

10. MARKUSSEN DL, Kommedal O, Knoop ST, Ebbesen MH, et al
    Microbial aetiology of community-acquired pneumonia in hospitalized adults: a prospective study utilising comprehensive molecular testing.
    Int J Infect Dis. 2024 Apr 4:107019. doi: 10.1016/j.ijid.2024.107019.
    

    >> Share

    
    
11. TAMURA K, Shimbashi R, Kasamatsu A, Chang B, et al
    Unveiling the role of preceding seasonal influenza in the development of bacteremic pneumococcal pneumonia in older adults before the COVID-19 pandemic in Japan.
    Int J Infect Dis. 2024 Apr 5:107024. doi: 10.1016/j.ijid.2024.107024.
    

    >> Share

    
    
12. FAVRESSE J, Gillot C, Cabo J, David C, et al
    Neutralizing antibody response to XBB.1.5, BA.2.86, FL.1.5.1 and JN.1 six months after the BNT162b2 bivalent booster.
    Int J Infect Dis. 2024 Apr 5:107028. doi: 10.1016/j.ijid.2024.107028.
    

    >> Share

    
    
13. YU J, Zhang K, Chen T, Lin R, et al
    Temporal patterns of organ dysfunction in COVID-19 patients hospitalized in the intensive care unit: A group-based multitrajectory modelling analysis.
    Int J Infect Dis. 2024 Apr 9:107045. doi: 10.1016/j.ijid.2024.107045.
    

    >> Share

    
    

    
    J Infect

14. PINANA M, Gonzalez-Sanchez A, Andres C, Vila J, et al
    Genomic evolution of human respiratory syncytial virus during a decade (2013-2023): bridging the path to monoclonal antibody surveillance.
    J Infect. 2024 Apr 6:106153. doi: 10.1016/j.jinf.2024.106153.
    

    >> Share

    
    

    
    J Med Virol

15. ARUNAN B, Talukdar D, Swain S, Varadarajan A, et al
    Metagenomic insights into fungal community composition of the nasopharyngeal region of COVID-19 associated mucormycosis patients from India.
    J Med Virol. 2024;96:e29601.
    

    >> Share

    
    
16. LI Y, Yu J, Wang Y, Yi J, et al
    Cocirculation and coinfection of multiple respiratory viruses during autumn and winter seasons of 2023 in Beijing, China: A retrospective study.
    J Med Virol. 2024;96:e29602.
    

    >> Share

    
    
17. PARK D, Kim SM, Jang H, Kim K, et al
    Differential beta-coronavirus infection dynamics in human bronchial epithelial organoids.
    J Med Virol. 2024;96:e29600.
    

    >> Share

    
    
18. SVIERCZ F, Jarmoluk P, Godoy Coto J, Cevallos C, et al
    The abortive SARS-CoV-2 infection of osteoclast precursors promotes their differentiation into osteoclasts.
    J Med Virol. 2024;96:e29597.
    

    >> Share

    
    
19. RAI P, Marano JM, Kang L, Coutermarsh-Ott S, et al
    Obesity fosters severe disease outcomes in a mouse model of coronavirus infection associated with transcriptomic abnormalities.
    J Med Virol. 2024;96:e29587.
    

    >> Share

    
    
20. KURYLOWICZ A, Babicki M, Wasowski M, Jankowski P, et al
    Triglicerydes/high-density lipoprotein ratio as a risk factor of post-Covid-19 sinus tachycardia: A retrospective study.
    J Med Virol. 2024;96:e29586.
    

    >> Share

    
    
21. YE G, Tang Y, Yang Q, Zhang C, et al
    A peptide derived from SARS-CoV-2 nucleocapsid protein with broad-spectrum anti-coronavirus activity.
    J Med Virol. 2024;96:e29492.
    

    >> Share

    
    

    
    J Travel Med

22. CHEMAITELLY H, Coyle P, Kacem MAB, Ayoub HH, et al
    Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant.
    J Travel Med. 2024 Apr 9:taae053. doi: 10.1093.
    

    >> Share

    
    

    
    J Virol

23. BOON ACM, Bricker TL, Fritch EJ, Leist SR, et al
    Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19.
    J Virol. 2024 Apr 9:e0190323. doi: 10.1128/jvi.01903.
    

    >> Share

    
    
24. ZHOU J, Sun P, Wang Y, Qiu R, et al
    Deep profiling of potential substrate atlas of porcine epidemic diarrhea virus 3C-like protease.
    J Virol. 2024 Apr 9:e0025324. doi: 10.1128/jvi.00253.
    

    >> Share

    
    
25. YANG R, Han P, Han P, Li D, et al
    Molecular basis of hippopotamus ACE2 binding to SARS-CoV-2.
    J Virol. 2024 Apr 9:e0045124. doi: 10.1128/jvi.00451.
    

    >> Share

    
    

    
    JAMA

26. HARRIS E
    COVID-19 Vaccination Linked With Lower Risk of Cardiac Problems.
    JAMA. 2024 Apr 12. doi: 10.1001/jama.2024.5152.
    

    >> Share

    
    
27. DAWOOD FS, Payne AB, McMorrow ML
    Assessing the Real-World Effectiveness of Immunizations for Respiratory Syncytial Virus.
    JAMA. 2024 Apr 11. doi: 10.1001/jama.2024.5859.
    

    >> Share

    
    

    
    Lancet

28. 
    Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021.
    Lancet. 2024 Apr 3:S0140-6736(24)00367-2. doi: 10.1016/S0140-6736(24)00367.
    

    >> Share

    
    
29. GU X, Huang L, Zhang H, Cao B, et al
    Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan - Authors' reply.
    Lancet. 2024;403:1336-1337.
    

    >> Share

    
    
30. SORAAS A, Brunvoll SH, Nygaard AB, Dahl JA, et al
    Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan.
    Lancet. 2024;403:1336.
    

    >> Share

    
    
31. HASHIM Z, Nath A, Tripathy NK
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337-1338.
    

    >> Share

    
    
32. MCEVOY N, Lowry J, O'Dowd A, Curley GF, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1337.
    

    >> Share

    
    
33. HSU NC, Tokuda Y
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338.
    

    >> Share

    
    
34. NARASARAJU T, Ravi Y, Jonsson CB, Chow VTK, et al
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1338-1339.
    

    >> Share

    
    
35. BHUSAL S, Adhikari S
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial.
    Lancet. 2024;403:1339.
    

    >> Share

    
    
36. PETO L, Basnyat B, Horby P
    High-dose corticosteroid therapy in COVID-19: the RECOVERY trial - Authors' reply.
    Lancet. 2024;403:1339-1340.
    

    >> Share

    
    
37. ZUMLA A, Peiris M, Memish ZA, Perlman S, et al
    Anticipating a MERS-like coronavirus as a potential pandemic threat.
    Lancet. 2024 Apr 8:S0140-6736(24)00641-X. doi: 10.1016/S0140-6736(24)00641.
    

    >> Share

    
    

    
    Lancet Infect Dis

38. PELUSO MJ, Swank ZN, Goldberg SA, Lu S, et al
    Plasma-based antigen persistence in the post-acute phase of COVID-19.
    Lancet Infect Dis. 2024 Apr 8:S1473-3099(24)00211.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

39. DOSHI RH, Nsasiirwe S, Dahlke M, Atagbaza A, et al
    COVID-19 Vaccination Coverage - World Health Organization African Region, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:307-311.
    

    >> Share

    
    
40. LIKO J, Cieslak PR
    Assessment of Risk for Sudden Cardiac Death Among Adolescents and Young Adults After Receipt of COVID-19 Vaccine - Oregon, June 2021-December 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:317-320.
    

    >> Share

    
    

    
    N Engl J Med

41. HAMMOND J, Fountaine RJ, Yunis C, Fleishaker D, et al
    Nirmatrelvir for Vaccinated or Unvaccinated Adult Outpatients with Covid-19.
    N Engl J Med. 2024;390:1186-1195.
    

    >> Share

    
    
42. GANDHI RT, Hirsch M
    Treating Acute Covid-19 - Final Chapters Still Unwritten.
    N Engl J Med. 2024;390:1234-1236.
    

    >> Share

    
    

    
    Zhonghua Jie He He Hu Xi Za Zhi

43. SUN ZZ, Sun GF, Zhuang R, Zhu LQ, et al
    [Best evidence summary for awake prone positioning in treating hypoxemic due to COVID-19 infection].
    Zhonghua Jie He He Hu Xi Za Zhi. 2024;47:313-318.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share